In bid to ad­vance man­u­fac­tur­ing ca­pa­bil­i­ties, In­scrip­ta buys out two biotechs

A life sci­ences com­pa­ny just bought out two syn­thet­ic bi­ol­o­gy com­pa­nies to add to its man­u­fac­tur­ing ar­se­nal.

Genome en­gi­neer and syn­bio out­fit In­scrip­ta put out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER